SCHEMBL2363976

SCHEMBL2363976

NC(=O)c1ccccc1Cc1ccc2c[nH]cc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.46
▸ KDM4E B2RXH2 3/20 0.46
▸ LMNA P02545 1/20 0.46
▸ TSHR P16473 2/20 0.42
▸ CAPN1 P07384 1/20 0.42
▸ TBXA2R P21731 1/20 0.41
▸ PTGER4 P35408 1/20 0.41
▸ PTGFR P43088 1/20 0.41
▸ PTGER3 P43115 1/20 0.41
▸ PTGER2 P43116 1/20 0.41
▸ PTGDR Q13258 1/20 0.41
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ GAA P10253 1/20 0.37
▸ ALOX5 P09917 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28177161 0.86 TBXA2R (0.54) ALDH1A1KDM4ELMNATSHRCAPN1
SCHEMBL3459871 0.76 MAPK8 (0.46) ALDH1A1KDM4ELMNATSHRCA1
SCHEMBL3461063 0.76 TBXA2R (0.55) ALDH1A1KDM4ELMNATSHRTBXA2R
SCHEMBL3461101 0.76 ADRA1D (0.49) ALDH1A1KDM4ELMNAPARP1MEN1
SCHEMBL3462285 0.76 MAPK8 (0.48) KDM4EGAAPARP1
SCHEMBL1004028 0.76 TSHR (0.58) ALDH1A1KDM4ETSHRCAPN1CA1
SCHEMBL7134588 0.75 TSHR (0.54) ALDH1A1KDM4ETSHRGAACYP2C9
SCHEMBL5723934 0.74 KEAP1 (0.56) ALDH1A1KDM4ETSHRCA1CA2
SCHEMBL19439093 0.74 TSHR (0.53) ALDH1A1KDM4ELMNATSHRCAPN1
Hydrochloric Acid SCHEMBL15690391 0.74 TSHR (0.56) ALDH1A1KDM4ETSHRCAPN1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2358697-A1 Isoindoline compounds for use in the treatment of cancer CELGENE CORPORATION (US) 2011-08-24 — — EP disclosed
WO-2010053732-A1 ISOINDOLINE COMPOUNDS FOR USE IN THE TREATMENT OF CANCER CELGENE CORPORATION (US) 2010-05-14 — — WO disclosed
Send feedback